Matches in Nanopublications for { ?s ?p "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP830017.RAAwvOMEcStMoGgr7v7PjAA1G5X3AMdVn8-YTXaXFwlkU130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830017.RAAwvOMEcStMoGgr7v7PjAA1G5X3AMdVn8-YTXaXFwlkU130_provenance.
- NP589117.RAQx_O8NsysFOLjI4SRA0F3B_SEkuoCce0Qbz6mD5E_kw130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589117.RAQx_O8NsysFOLjI4SRA0F3B_SEkuoCce0Qbz6mD5E_kw130_provenance.
- NP712577.RAa91taVPXEMC1AmpFXtpNSPgULz-9cPQEauPymXuVwtE130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712577.RAa91taVPXEMC1AmpFXtpNSPgULz-9cPQEauPymXuVwtE130_provenance.
- NP830020.RATM6uoGqfMt8DXZjWpCbJi9ugZXgkQTUhwxxMN6ZTrAI130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830020.RATM6uoGqfMt8DXZjWpCbJi9ugZXgkQTUhwxxMN6ZTrAI130_provenance.
- NP589534.RAHe9-aOOhIHn17WsCxp4Nr9NA1gY2cWcmFM49KkDrQBo130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589534.RAHe9-aOOhIHn17WsCxp4Nr9NA1gY2cWcmFM49KkDrQBo130_provenance.
- NP712699.RALVrPwKUOt9aGZNOupygDO533G83W4bgJmqbgP_S2ORk130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712699.RALVrPwKUOt9aGZNOupygDO533G83W4bgJmqbgP_S2ORk130_provenance.
- NP836017.RANN8sWHuZ_nqONqbhqxtAv0TTVZriQGSc0QtxB7RCdTI130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836017.RANN8sWHuZ_nqONqbhqxtAv0TTVZriQGSc0QtxB7RCdTI130_provenance.
- NP830016.RAIlG2FO3kMkH1GN0USAdlLJok7PPfur6zrsYpo49YoXQ130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830016.RAIlG2FO3kMkH1GN0USAdlLJok7PPfur6zrsYpo49YoXQ130_provenance.
- NP830019.RAMUlB3eZQ-xC9zwHqS2EYstnQ2oIRv-1YEefsS12NXPA130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830019.RAMUlB3eZQ-xC9zwHqS2EYstnQ2oIRv-1YEefsS12NXPA130_provenance.
- NP830018.RAm81O2yXkmUtaWlCuzV7vihvFC1uq705t54hN8ovlMsw130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830018.RAm81O2yXkmUtaWlCuzV7vihvFC1uq705t54hN8ovlMsw130_provenance.
- NP830021.RAlPoKxljViXjH8x6CaaDif5LHc3znZaWEdk5QAmiqLyo130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830021.RAlPoKxljViXjH8x6CaaDif5LHc3znZaWEdk5QAmiqLyo130_provenance.
- NP836040.RAgXxwhNl4QiBY_UC0qLjjHhBRaYqLSWAMim-Fahg_PN8130_assertion description "[Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRα that leads to SREBP-1c induction and hepatic steatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836040.RAgXxwhNl4QiBY_UC0qLjjHhBRaYqLSWAMim-Fahg_PN8130_provenance.